Cargando…

Hepatitis B Virus Cure: Targets and Future Therapies

Chronic hepatitis B virus (HBV) infection is a major global health problem. It can cause progressive liver fibrosis leading to cirrhosis with end-stage liver disease, and a markedly increased risk of hepatocellular carcinoma. In the last two decades, substantial progress has been made in the treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hye Won, Lee, Jae Seung, Ahn, Sang Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795643/ https://www.ncbi.nlm.nih.gov/pubmed/33379331 http://dx.doi.org/10.3390/ijms22010213

Ejemplares similares

Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus
por: Kim, Sun Woong, et al.
Publicado: (2022)

Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy
por: Lee, Jae Seung, et al.
Publicado: (2021)

Targeting lipid biosynthesis pathways for hepatitis B virus cure
por: Hyrina, Anastasia, et al.
Publicado: (2022)

Targeted Therapy of Hepatitis B Virus-Related Hepatocellular Carcinoma: Present and Future
por: Koh, Sarene, et al.
Publicado: (2016)

Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients
por: Lee, Hye Won, et al.
Publicado: (2016)

Metastasis-Directed Local Therapy of Hepatic Oligometastasis from Colorectal Cancer and Future Perspective in Radiation Therapy
por: Yoo, Gyu Sang, et al.
Publicado: (2023)

Combination of Pegylated Interferon and Nucleos(t)ide Therapy: Toward a Cure of Hepatitis B Virus Infection?
por: Cho, Eun Ju, et al.
Publicado: (2016)

Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy
por: Chang, Jin Won, et al.
Publicado: (2021)

Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
por: Lee, Jae Seung, et al.
Publicado: (2022)

Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals
por: Lee, Hye Won, et al.
Publicado: (2020)

Hepatitis B virus–host interactions and novel targets for viral cure
por: Ligat, Gaëtan, et al.
Publicado: (2021)

Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection
por: Zeisel, Mirjam B., et al.
Publicado: (2015)

External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study
por: Lee, Jae Seung, et al.
Publicado: (2022)

What will it take to cure hepatitis B?
por: Jeng, Wen-Juei, et al.
Publicado: (2023)

Quasispecies and Pre-Existing Drug-Resistant Mutations of Hepatitis B Virus in Patients with Chronic Hepatitis B
por: Kim, Do Young, et al.
Publicado: (2013)

Aiming for Functional Cure With Established and Novel Therapies for Chronic Hepatitis B
por: Choi, Hannah S.J., et al.
Publicado: (2021)

Therapeutic strategies for a functional cure of chronic hepatitis B virus infection
por: Chang, Jinhong, et al.
Publicado: (2014)

Hepatitis E virus as an emerging zoonotic pathogen
por: Park, Woo-Jung, et al.
Publicado: (2016)

Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis
por: Park, Jihye, et al.
Publicado: (2017)

The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
por: Lee, Hye Won, et al.
Publicado: (2021)

New Viral and Immunological Targets for Hepatitis B Treatment and Cure: A Review
por: Arends, Joop E., et al.
Publicado: (2017)

Predictive validation of qualitative fibrosis staging in patients with chronic hepatitis B on antiviral therapy
por: Lee, Hye Won, et al.
Publicado: (2019)

Phytomedicines to Target Hepatitis B Virus DNA Replication: Current Limitations and Future Approaches
por: Sadiea, Rahila Zannat, et al.
Publicado: (2022)

Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
por: Jeon, Mi Young, et al.
Publicado: (2021)

Clinical Implications of Hepatitis B Virus RNA and Covalently Closed Circular DNA in Monitoring Patients with Chronic Hepatitis B Today with a Gaze into the Future: The Field Is Unprepared for a Sterilizing Cure
por: Kostyusheva, Anastasiya, et al.
Publicado: (2018)

Discussion on critical points for a tailored therapy to cure hepatitis C virus infection
por: Marascio, Nadia, et al.
Publicado: (2019)

Future Therapy for Hepatitis B Virus: Role of Immunomodulators
por: Pham, Edward A., et al.
Publicado: (2016)

Host-targeting therapies for hepatitis C virus infection: current developments and future applications
por: Crouchet, Emilie, et al.
Publicado: (2018)

Targeting Host Innate and Adaptive Immunity to Achieve the Functional Cure of Chronic Hepatitis B
por: Ezzikouri, Sayeh, et al.
Publicado: (2020)

Time for an active antiviral therapy for hepatitis B: An update on the management of hepatitis B virus infection
por: Chae, Hee Bok, et al.
Publicado: (2007)

Functional Cure of Hepatitis B Virus Infection in Individuals With HIV-Coinfection: A Literature Review
por: Boyd, Anders, et al.
Publicado: (2021)

Assessing immunological and virological responses in the liver: Implications for the cure of chronic hepatitis B virus infection
por: Boettler, Tobias, et al.
Publicado: (2022)

Toward a new era of hepatitis B virus therapeutics: The pursuit of a functional cure
por: Tsounis, Efthymios P, et al.
Publicado: (2021)

Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection
por: Meng, Zhongji, et al.
Publicado: (2020)

Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
por: Kim, David Sooik, et al.
Publicado: (2019)

Hepatitis C Virus and Antiviral Drug Resistance
por: Kim, Seungtaek, et al.
Publicado: (2016)

Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B
por: Kim, Eun Hye, et al.
Publicado: (2013)

Emerging Therapies for Hepatitis C
por: Kim, Do Young, et al.
Publicado: (2014)

Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure
por: Shinn, Brianna J, et al.
Publicado: (2019)

Targeting Viral cccDNA for Cure of Chronic Hepatitis B
por: Ligat, Gaëtan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0fa80ko1bf1nh54ar7m7jaev00